Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory bowel disease and carcinogenesis
Hiroko Nagao‐Kitamoto, Sho Kitamoto, Nobuhiko Kamada
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 2, pp. 301-316
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Oxidative Stress, Inflammation and Colorectal Cancer: An Overview
Annamária Bardelčíková, Jindřich Šoltýs, Ján Mojžíš
Antioxidants (2023) Vol. 12, Iss. 4, pp. 901-901
Open Access | Times Cited: 100
Advances of Wnt Signalling Pathway in Colorectal Cancer
Yaoyao Zhu, Xia Li
Cells (2023) Vol. 12, Iss. 3, pp. 447-447
Open Access | Times Cited: 50
Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer
D. Sh. Dzhalilova, Н. А. Золотова, Nikolai Fokichev, et al.
PeerJ (2023) Vol. 11, pp. e16159-e16159
Open Access | Times Cited: 24
Advances in AI-assisted biochip technology for biomedicine
Didem Rodoplu
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116997-116997
Closed Access | Times Cited: 8
The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in colorectal cancer and colorectal anastomotic leakage patients: a retrospective study
Nuo Xu, Jianxin Zhang, Jiajie Zhang, et al.
BMC Surgery (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study
Xiaorong Yang, Lejin Yang, Tongchao Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study
Huantian Cui, Yutong Jin, Ning Wang, et al.
Phytomedicine (2024) Vol. 128, pp. 155509-155509
Closed Access | Times Cited: 7
Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review)
Zhi Wang, Yu Chang, Sun Haibo, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 6
Purple Yam Polyphenol Extracts Exert Anticolitis and Anticolitis-Associated Colorectal Cancer Effects through Inactivation of NF-κB/p65 and STAT3 Signaling Pathways
Xinyue Yang, Qing Wang, Xinghai Zhang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 32, pp. 12177-12189
Closed Access | Times Cited: 15
Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing
Rizwan Ahmad, Balawant Kumar, Ishwor Thapa, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 23
Open Access | Times Cited: 14
Examination of non-conventional dysplasias adjacent to colorectal adenocarcinoma in patients with IBD
Szintia Almási, Zoltán Balajthy, Bence Baráth, et al.
Pathology & Oncology Research (2025) Vol. 30
Open Access
Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer
Tianyi Chen, Jiachen Liu, Ruyi Hang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 925-947
Open Access
Temporal and Spatial Metabolic Shifts Revealing the Transition from Ulcerative Colitis to Colitis‐Associated Colorectal Cancer
Ruiqi Sun, Yuanyuan Zhang, Xian Zhao, et al.
Advanced Science (2025)
Open Access
Deciphering the Interplay Among Inflammatory Bowel Disease, Gut Microbiota, and Inflammatory Biomarkers in the Risk of Colorectal Cancer
Chenyu Luo, Bowen Tian, Yueyang Zhou, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells
Martina Spada, Cristina Piras, Giulia Diana, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 683-683
Open Access | Times Cited: 12
Photodynamic Therapy for Inflammatory and Cancerous Diseases of the Intestines: Molecular Mechanisms and Prospects for Application
Beiying Deng, Kunpeng Wang, Lilong Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4793-4810
Open Access | Times Cited: 12
Advances in research on the effectiveness and mechanism of Traditional Chinese Medicine formulas for colitis-associated colorectal cancer
Xiunan Wei, Xiaohui Leng, Gongyi Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?
Katia Fettucciari, Alessandro Fruganti, Fabrizio Stracci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8155-8155
Open Access | Times Cited: 11
Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3
Aihua Wu, Daoquan Fang, Yangyang Liu, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4730-4744
Open Access | Times Cited: 11
Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer
Lena Van Dingenen, Charlotte Segers, Shari Wouters, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma
Xin Zhao, Yuan Zhou, Bing Liu, et al.
Medical Science Monitor (2023) Vol. 29
Open Access | Times Cited: 9
Recent developments on BMPs and their antagonists in inflammatory bowel diseases
Zhuo Xie, Gaoshi Zhou, Mudan Zhang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms
Peng Xu, Tao Zuo, Hua Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Genetics, diet, microbiota, and metabolome: partners in crime for colon carcinogenesis
Marta La Vecchia, G. Sala, Marika Sculco, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
CRISPR/Cas9: a powerful tool in colorectal cancer research
Yang Hu, Liang Liu, Qi Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top